14 before 0900, 18 between 0900 and 1200, 3 between 1200 and 1700, and 5 after 1700.
The blood sample collection times for the 300 serumn digoxin concentrations available for full analysis were: 16 (5%) before 0900,25 (8%) between 0900 and 1200, 245 (82%) between 1200
and 1700, and 14 (5%) after 1700. The distribution of the digoxin determinations falling within specified intervals is shown in Table 2 . For all patients, there were few (4%) digoxin serum concentrations >2 p.g/L and 55% were between 0.9 and To evaluate the appropriateness of these tests with regards to the timing from the last dl(aseof digoxin, we analyzed the 300 tests can the selected patients. As shown in Table 2 of the time and 3 were subtherapeutic >90% of the time.
In these three patients 18 of 18, 12 of 13, and 6 of 6 serum digoxin determinations were subtherapeutic.
Discussion
The utility of digoxin TDM includes: (a) confirmation of a diagnosis of digoxin toxicity, and (b) assistance in achieving effective patient-specific digoxin dosage. 
